MI HR0119 | 2023-2024 | 102nd Legislature

Status

Completed Legislative Action
Spectrum: Slight Partisan Bill (Democrat 17-7)
Status: Passed on June 27 2023 - 100% progression
Action: 2023-06-27 - Adopted
Text: Latest bill text (Enrolled) [HTML]

Summary

A resolution to urge the United States Food and Drug Administration to facilitate FDA regulated research on hyperbaric oxygen therapy for the treatment of Traumatic Brain Injury and Post Traumatic Stress Disorder.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

A resolution to urge the United States Food and Drug Administration to facilitate FDA regulated research on hyperbaric oxygen therapy for the treatment of Traumatic Brain Injury and Post Traumatic Stress Disorder.

Sponsors


Roll Calls

2023-06-13 - House - Reported With Recommendation Without Amendment (Y: 8 N: 0 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2023-06-27HouseAdopted
2023-06-13HouseReported With Recommendation Without Amendment
2023-06-08HouseReferred To Committee On Military, Veterans And Homeland Security
2023-06-08HouseIntroduced By Representative Julie M. Rogers

Michigan State Sources


Bill Comments

feedback